Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (HAIC-quad) is evaluating hepatic arterial infusion chemotherapy combined with durvalumab and lenvatinib for locally advanced or metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• IMFINZI (DURVALUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: West China Hospital | Conditions: Intrahepatic Cholangiocarcinoma (Icc), HAIC | Phase 2 | Status: RECRUITING